Бегущая строка

ARTO.PA $5 000.00 0%
PRQR $1.91 -4.9751%
BXP.L $37.45 -0.1333%
2120.HK $12.10 0%
KRW.L $62.09 -1.044%
BCSA $10.39 -0.0961%
1343.HK $0.12 2.5862%
X1G.PA $212.91 -0.5427%
1935.HK $1.12 0%
SWBK $9.35 0%
RHCB $45.43 0%
PRIM.L $3.15 0%
KTTAW $0.02 0%
CATY $28.07 0.107%
VIVE $0.05 -11.0902%
HMED.L $46.53 0%
TWCT $10.06 0%
PSA-PL $21.68 -0.1842%
PDCE $62.08 1.3055%
8121.HK $0.20 6.2827%
MNMD $3.05 -1.2718%
MAAQR $0.56 0%
PRVB $24.98 0%
0QND.L $94.22 0.0631%
SDHG.L $68.52 -0.0338%
3928.HK $0.63 0%
PFX $35.01 -0.7372%
SUAP.L $4.83 0.0932%
UPV $56.00 -1.2708%
SERA $3.41 -2.4629%
KSICU $10.13 0%
PAMC $33.12 -0.0075%
EWQ $38.62 -0.7963%
XPO $46.96 -0.1701%
EMFM $18.87 -0.5796%
CFEB.BR $10.42 1.7578%
VFIN $3.65 0%
SIZ $17.35 0%
BVA.L $6.61 1.4203%
ORR.L $0.23 9.7561%
HPAO.L $17.70 0.2208%
ALPA $10.20 0.0981%
BMOB3.SA $13.82 -2.6761%
1628.HK $0.24 0%
ESGN $27.27 0.2165%
GRTX $3.14 0.8039%
THAL.L $31.00 0%
GLU $14.07 0.1423%
BVX.L $15.00 0%
BNKU $12.30 -2.6899%
TZPS $10.15 0%
CUBS $19.78 0.401%
SNGA.L $321.99 0.5402%
THRG.L $594.00 0%
0925.HK $0.07 2.7778%
GBSP.L $1 061.13 -0.3755%
NRR.L $82.80 -0.6002%
0950.HK $1.55 -0.641%
OGEN $3.32 3.6593%
MACP.L $1.88 0%
JRS $7.21 -0.3458%
CCNC $3.02 -37.835%
BVXV $1.79 -1.105%
0661.HK $0.07 -2.9851%
7231.HK $3.43 0%
0LI9.L $174.53 -5.0952%
0S10.L $4.83 1.5268%
RICE-UN $21.54 0%
SCHW-PJ $19.46 0.4486%
0TZZ.L $458.41 -0.4798%
PFIS $34.80 -1.8889%
GLBLW $0.55 0%
JHME $34.55 0%
0Z4I.L $81.88 0.7792%
BNDD $15.52 0.4875%
FSLF $15.78 0%
2136.HK $1.12 0%
MRK $116.82 -0.621%
ELC $23.33 0.4737%
PRA $14.53 -0.4795%
0703.HK $0.24 0.4202%
RGTI $0.44 -11.9%
MLWIZ.PA $8.25 0%
EQH-PC $16.30 -0.8516%
AMC.L $1.70 1.4948%
FINMW $0.00 0%
PFLD $20.07 0.0499%
MNO.L $12.50 0%
BWG $7.79 -0.3836%
SOS $3.72 -2.6178%
0196.HK $0.20 3.5533%
BGSC.L $140.60 0%
CBRGW $0.07 0%
PEB-PG $18.82 0.0532%
GHC $579.10 -0.0846%
ASG $5.01 -0.497%
2888.HK $60.85 0.0822%
SAPR4.SA $4.09 3.2828%
NUSI $19.90 -0.2627%
IWP $88.49 -0.7181%

Хлебные крошки

Акции внутренные

Лого

Predictive Oncology Inc. POAI

$3.77

-$0.08 (-2.21%)
На 18:01, 12 мая 2023

Ранг: 3

Ранг - это оценка кредитоспособности корпорации.

Ключевые показатели

  • Marketcap

    14805079.00000000

  • week52high

    14.80

  • week52low

    2.47

  • Revenue

    1505459

  • P/E TTM

    -5

  • Beta

    1.39930700

  • EPS

    -8.23000000

  • Last Dividend

    0.00000000

  • Next Earnings Date

    10 мая 2023 г. в 10:59

Описание компании

Predictive Oncology Inc., a knowledge-driven company, focuses on developing personalized cancer therapies using artificial intelligence (AI) primarily in the United States. The company operates in four segments: Helomics, zPREDICTA, Soluble, and Skyline. The Helomics segment offers clinical testing services comprising tumor drug response testing and genomic profiling tests; and contract research services through patient-centric drug discovery using active learning technology for discovery, clinical and translational research, clinical trials, and diagnostic development and validation. The zPREDICTA segment develops organ-specific disease models that provide 3D reconstruction of human tissues representing each disease state and mimicking drug response for testing of anticancer agents. The Soluble segment provides services using High-Throughput Self-Interaction Chromatography, a self-contained, automated system that conducts high-throughput, self-interaction chromatography screens using additives and excipients that are included in protein formulations for soluble and physically stable formulations for biologics. This segment also offers protein stability analysis services; protein solubility kits that allow rapid identification of soluble formulations; and proprietary technologies for bacterial endotoxin detection and removal. The Skyline segment provides STREAMWAY System, a wall-mounted fully automated system, which virtually eliminates staff exposure to blood, irrigation fluid, and other infectious fluids found in the healthcare environment. It also offers research and development services; and media that help cancer cells grow outside the patient's body and retain their DNA/RNA and proteomic signatures. The company was formerly known as Precision Therapeutics Inc. and changed its name to Predictive Oncology Inc. in June 2019. Predictive Oncology Inc. was incorporated in 2002 and is based in Eagan, Minnesota.

Рекомендации
аналитиков

Рекомендации аналитиков — понятие, что это такое и как.

Рекомендации аналитиков

Grading company New grade Previous grade Recommendation date
HC Wainwright & Co. Buy 30 июн 2021 г.

Свежие комментарии

Свежие комментарии

Оставьте свой голос

Оставьте свой голос

Анонимное голосование

Будет ли рост российского рынка к концу года?

  • Да

    87%
  • Нет

    12%

Проголосовал 8 человек

Новостная лента
компании

Новостная лента

  • Изображение

    Predictive Oncology appoints healthcare commercial and business development veteran to its board

    Proactive Investors

    03 мая 2023 г. в 08:19

    Predictive Oncology Inc. (NASDAQ:POAI) said it has appointed healthcare commercial and business development veteran Dr Veena Rao to its board of directors. Dr Rao will replace David Smith, who is stepping down but will remain an advisor to the board and assume duties as legal counsel to the company.

  • Изображение

    3 Undiscovered AI Stocks Set to Dominate the Market

    InvestorPlace

    03 мая 2023 г. в 06:00

    Artificial intelligence is one of the hottest stories of the year. Investors who believe in the technology, or who are simply looking to find growth wherever they can, are flocking into AI stocks.

  • Изображение

    Penny Stocks To Buy? 10 Under $1 To Watch This Week

    PennyStocks

    19 апр 2023 г. в 15:29

    Penny stocks under $1 to watch this week. The post Penny Stocks To Buy?

  • Изображение

    Penny Stocks To Buy? 7 Under $1 To Watch This Week

    PennyStocks

    17 апр 2023 г. в 11:15

    Penny stocks to watch trading for pennies this week. The post Penny Stocks To Buy?

  • Изображение

    Predictive Oncology appoints translational research leader Christoph Reinhard to scientific advisory board

    Proactive Investors

    04 апр 2023 г. в 09:34

    Predictive Oncology Inc. (NASDAQ:POAI) announced the appointment of Dr. Christoph Reinhard to its scientific board to serve alongside other key thought leaders in their fields to guide the company's scientific initiatives and growth strategy.



Insider Summary

Insider Summary

Reporting Name Acquistion/Disposition Owned Transacted Transaction Date
Nuzum Charles Lee Sr A 579704 53539 25 янв 2023 г.
Smith David Stewart A 90666 71755 03 янв 2023 г.
HANDLEY DANIEL E A 183935 63422 03 янв 2023 г.
Hawryluk Matthew A 33332 19570 03 янв 2023 г.
Vennare Raymond F A 142438 58708 03 янв 2023 г.
ST. CLAIR GREGORY SR A 220211 99664 03 янв 2023 г.
Nuzum Charles Lee Sr A 526165 172150 03 янв 2023 г.
CHUNG-WELCH NANCY A 229839 97848 03 янв 2023 г.
HANDLEY DANIEL E A 120513 6000 15 дек 2022 г.
Vennare Raymond F A 83730 400 02 дек 2022 г.